Managing heart failure better: the value of implantable device data

Mo Med. 2008 Sep-Oct;105(5):441-6.

Abstract

The heart failure disease state is challenging, time consuming and expensive to manage. Physicians are responsible for initiating, titrating and optimizing drug and device therapy to reduce morbidity and mortality. Failure to manage these aspects of care often results in worsening of symptoms and recurrent hospitalizations. This paper reviews the data implantable devices provide and how this data can assist in optimally managing the patient with heart failure.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Aged
  • Atrial Fibrillation / therapy
  • Defibrillators, Implantable*
  • Female
  • Heart Failure / physiopathology*
  • Heart Failure / therapy
  • Humans
  • Male
  • Middle Aged
  • Pacemaker, Artificial
  • Patient Compliance
  • Water-Electrolyte Balance / physiology

Substances

  • Adrenergic beta-Antagonists